| Polymedco Introduces Point Of Care Test For Recurrent Bladder Cancer Detection (Medical News Today) |
|
|
Polymedco, Inc. is pleased to announce the direct availability of the BTA stat(R) test from our sales force -- The BTA stat(R) test is a point of care technology for the early detection of recurrent bladder cancer. This method uses monoclonal antibodies to detect the presence of bladder tumor associated antigen in urine. |